NTLA
Intellia Therapeutics, Inc. · Healthcare
President and CEO John M Leonard sold $3.4M of Intellia Therapeutics, Inc.
Sold$3,431,398
$151.28Price
22,682Shares
−3%Stake
What NTLA did after the filing
- The stock from Mon, Aug 23 open, $153.12
- −15.3%
- S&P 500, same days
- −2.4%
Measured over 30 trading days, to the Oct 5 close.
Traded Thu, Aug 19. Filed Fri, Aug 20, 6:14 PM ET, after the close. Returns use the Aug 23 open and the Oct 5 close. Not investment advice.